A detailed history of First National Advisers, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, First National Advisers, LLC holds 70,752 shares of ABT stock, worth $8.16 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
70,752
Previous 65,636 7.79%
Holding current value
$8.16 Million
Previous $6.82 Million 18.27%
% of portfolio
1.3%
Previous 1.26%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.07 - $118.13 $511,958 - $604,353
5,116 Added 7.79%
70,752 $8.07 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $928,226 - $1.04 Million
9,215 Added 16.33%
65,636 $6.82 Million
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $1.23 Million - $1.36 Million
11,253 Added 24.91%
56,421 $6.41 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $1.13 Million - $1.38 Million
12,496 Added 38.25%
45,168 $4.97 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $1.52 Million - $1.82 Million
15,860 Added 94.34%
32,672 $3.16 Million
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $283,695 - $316,096
2,815 Added 20.11%
16,812 $1.83 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $368,939 - $434,264
3,809 Added 37.39%
13,997 $1.42 Million
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $90,972 - $106,724
957 Added 10.37%
10,188 $1.12 Million
Q3 2022

Nov 04, 2022

BUY
$96.76 - $112.03 $269,863 - $312,451
2,789 Added 43.29%
9,231 $893,000
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $657,534 - $794,749
6,442 New
6,442 $700,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track First National Advisers, LLC Portfolio

Follow First National Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First National Advisers, LLC with notifications on news.